Depressive Kernsymptome

Akiskal H, Bourgeois ML, Angst J et al (2000) Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J Affect Disord 59 [Suppl 1]:5–30

Akiskal HS, Benazzi F (2006) The DSM-IV and ICD-10 categories of recurrent major depressive and bipolar II disorders: Evidence that they lie on a dimensional spectrum. J Affect Disord 92:45–54

American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders. 4rd ed rev Washington DC

American Psychiatric Association Committee on Electroconvulsive Therapy, Weiner RD, Coffey CE et al (2001) The Practice of Electroconvulsive Therapy. American Psychiatric Association, Washington

Anderson IM (1998) SSRIS versus tricyclic antidepressants in depressed inpatients: A meta-analysis of efficacy and tolerability. Depress Anxiety 7 [Suppl 1]:11–17

Anderson IM (2000) Selective serotonin reuptake inhibitors versus tricyclic antidepressants: A meta-analysis of efficacy and tolerability. J Affect Disord 58:19–36

Andrews JM, Nemeroff CB (1994) Contemporary management of depression. Am J Med 97:24S–32S

Angst J (2006) Do many patients with depression suffer from bipolar disorder? Can J Psychiatry 51:3–5

Angst J, Dobler-Mikola A (1985) The Zurich Study – a prospective epidemiological study of depressive, neurotic and psychosomatic syndromes. IV. Recurrent and nonrecurrent brief depression. Eur Arch Psychiatry Neurol Sci 234:408–416

Angst J, Gamma A, Benazzi F et al (2007) Melancholia and atypical depression in the Zurich study: Epidemiology, clinical characteristics, course, comorbidity and personality. Acta Psychiatr Scand 115:72–84

Antiplatelet Trialists‘ Collaboration (1994) Collaborative overview of randomised trials of antiplatelet therapy–I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 308:81–106

Armitage R (2007) Sleep and circadian rhythms in mood disorders. Acta Psychiatr Scand 115:104–115

Azorin JM, Llorca PM, Despiegel N, Verpillat P (2004) Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder. Encephale 30:158–166

Baghai TC, Eser D, Moller HJ (2008) Effects of different antidepressant treatments on the core of depression. Dialogues Clin Neurosci 10:309–320

Baghai TC, Moller HJ (2008) Electroconvulsive therapy and its different indications. Dialogues Clin Neurosci 10:105–117

Barkin RL, Barkin S (2005) The role of venlafaxine and duloxetine in the treatment of depression with decremental changes in somatic symptoms of pain, chronic pain, and the pharmacokinetics and clinical considerations of duloxetine pharmacotherapy. Am J Ther 12:431–438

Bauer M, Adli M, Baethge C et al (2003) Lithium augmentation therapy in refractory depression: Clinical evidence and neurobiological mechanisms. Can J Psychiatry 48:440–448

Bauer M, Whybrow PC, Angst J et al (2002) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of unipolar depressive disorder,Part 1: Acute and continuation treatment of major depressive disorder. World J Biol Psychiatry 3:4–43

Bech P, Allerup P, Gram LF et al (1981) The Hamilton depression scale. Evaluation of objectivity using logistic models. Acta Psychiatr Scand 63:290–299

Birkenhager TK, Renes JW, Pluijms EM (2004) One-year follow-up after successful ECT: A naturalistic study in depressed inpatients. J Clin Psychiatry 65:87–91

Bolwig TG, Madsen TM (2007) Electroconvulsive therapy in melancholia: The role of hippocampal neurogenesis. Acta Psychiatr Scand 115:130–135

Brown WA (2007) Treatment response in melancholia. Acta Psychiatr Scand 115:125–129

Burke MJ, Preskorn SH (1995) Short term treatment of mood disorders with standard antidepressants. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: The fourth generation of progress. Raven Press, New York, pp 1053–1065

Cassano GB, Musetti L, Perugi G et al (1988) A proposed new approach to the clinical subclassification of depressive illness. Pharmacopsychiatry 21:19–23

Cipriani A, Barbui C, Brambilla P et al (2006) Are All Antidepressants Really the Same? The Case of Fluoxetine: A Systematic Review. J Clin Psychiatry 67:850–864

Coryell W (1996) Psychotic depression. J Clin Psychiatry 57 [Suppl 3]:27–31

Coryell W (2007) The facets of melancholia. Acta Psychiatr Scand 115:31–36

Danish University Antidepressant Group (1993) Moclobemide: A reversible MAO-A-inhibitor showing weaker antidepressant effect than clomipramine in a controlled multicenter study. J Affect Disord 28:105–116

Drevets WC (2000) Neuroimaging studies of mood disorders. Biol Psychiatry 48:813–829

Duman RS (2002) Synaptic plasticity and mood disorders. Mol Psychiatry 7 [Suppl 1]:29–34

Duman RS, Monteggia LM (2006) A Neurotrophic Model for Stress-Related Mood Disorders. Biol Psychiatry 59:1116–1127

Fava M (2002) Somatic symptoms, depression, and antidepressant treatment. J Clin Psychiatry 63:305–307

Fava M (2003) The role of the serotonergic and noradrenergic neurotransmitter systems in the treatment of psychological and physical symptoms of depression. J Clin Psychiatry 64 [Suppl 13]:26–29

Fink M (1990) Is Catatonia a Primary Indication for ECT? Convuls Ther 6:1–4

Fink M (1992) Catatonia and DSM-IV. Convuls Ther 8:159–162

Fink M, Taylor MA (2007) Resurrecting melancholia. Acta Psychiatr Scand 115:14–20

Fountoulakis KN, Iacovides A, Nimatoudis I et al (1999) Comparison of the diagnosis of melancholic and atypical features according to DSM-IV and somatic syndrome according to ICD-10 in patients suffering from major depression. Eur Psychiatry 14:426–433

Gendreau RM, Thorn MD, Gendreau JF et al (2005) Efficacy of milnacipran in patients with fibromyalgia. J Rheumatol 32:1975–1985

Gijsman HJ, Geddes JR, Rendell JM et al (2004) Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. Am J Psychiatry 161:1537–1547

Goldberg JF (2003) When do antidepressants worsen the course of bipolar disorder? J Psychiatr Pract 9:181–194

Grunze H, Kasper S, Goodwin G et al (2002) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression. World J Biol Psychiatry 3:115–124

Gupta RK, Moller HJ (2003) St. John’s Wort. An option for the primary care treatment of depressive patients? Eur Arch Psychiatry Clin Neurosci 253:140–148

Hameed U, Schwartz TL, Malhotra K et al (2005) Antidepressant treatment in the primary care office: Outcomes for adjustment disorder versus major depression. Ann Clin Psychiatry 17:77–81

Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62

Hegerl U, Pfeiffer-Gerschel T, Althaus D (2004) Elements for the effective treatment of patients with depressive disorders at the primary care level. MMW Fortschr Med 146 Spec No 2:10, 12–10, 14

Henkel V, Mergl R, Allgaier AK et al (2006) Treatment of depression with atypical features: A meta-analytic approach. Psychiatry Res 141:89–101

Henkel V, Mergl R, Coyne JC et al (2004) Depression with atypical features in a sample of primary care outpatients: Prevalence, specific characteristics and consequences. J Affect Disord 83:237–242

Judd LL, Akiskal HS, Maser JD et al (1998) A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gen Psychiatry 55:694–700

Kasper S (2001) Hypericum perforatum – a review of clinical studies. Pharmacopsychiatry 34 [Suppl 1]:51–55

Kasper S, Rogers SL, Madden PA et al (1990) The effects of phototherapy in the general population. J Affect Disord 18:211–219

Khan AY, Carrithers J, Preskorn SH et al (2006) Clinical and demographic factors associated with DSM-IV melancholic depression. Ann Clin Psychiatry 18:91–98

Kirsch I, Deacon BJ, Huedo-Medina TB et al (2008) Initial severity and antidepressant benefits: A meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 5:e45

Laakmann G, Faltermaier-Temizel M, Bossert-Zaudig S, Baghai T (1996) Are benzodiazepines antidepressants? Psychopharmacology (Berl) 124:291–292

Laakmann G, Schule C, Baghai T, Kieser M (1998) St. John’s wort in mild to moderate depression: The relevance of hyperforin for the clinical efficacy. Pharmacopsychiatry 31 [Suppl 1]:54–59

Lecrubier Y, Bech P (2007) The Ham D(6) is more homogenous and as sensitive as the Ham D(17). Eur Psychiatry 22:252–255

Leproult R, Van Onderbergen A, L’hermite-Baleriaux M et al (2005) Phase-shifts of 24-h rhythms of hormonal release and body temperature following early evening administration of the melatonin agonist agomelatine in healthy older men. Clin Endocrinol (Oxf) 63:298–304

Loo H, Dalery J, Macher JP, Payen A (2002) Pilot study comparing in blind the therapeutic effect of two doses of agomelatine, melatoninergic agonist and selective 5HT2C receptors antagonist, in the treatment of major depressive disorders. Encephale 28:356–362

Loo H, Dalery J, Macher JP, Payen A (2003) Pilot study comparing in blind the therapeutic effect of two doses of agomelatine, melatonin-agonist and selective 5HT2c receptors antagonist, in the treatment of major depressive disorders. Encephale 29:165–171

Mattia C, Paoletti F, Coluzzi F, Boanelli A (2002) New antidepressants in the treatment of neuropathic pain. A review. Minerva Anestesiol 68:105–114

Moller HJ (2008) Isn’t the efficacy of antidepressants clinically relevant? A critical comment on the results of the metaanalysis by Kirsch et al. 2008. Eur Arch Psychiatry Clin Neurosci 258:451–455

Möller HJ, Grunze H, Broich K (2006) Do recent efficacy data on the drug treatment of acute bipolar depression support the position that drugs other than antidepressants are the treatment of choice? A conceptual review. Eur Arch Psychiatry Clin Neurosci 256:1–16

Moller HJ, Maier W (2007) Problems of evidence-based medicine in psychopharmacotherapy: Problems of evidence grading and of the evidence basis for complex clinical decision making. Nervenarzt 78:1014–1027

Montgomery DB, Roberts A, Green M et al (1994) Lack of efficacy of fluoxetine in recurrent brief depression and suicidal attempts. Eur Arch Psychiatry Clin Neurosci 244:211–215

Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382–389

Montgomery SA, Baldwin DS, Blier P et al (2007) Which antidepressants have demonstrated superior efficacy? A review of the evidence. Int Clin Psychopharmacol 22:323–329

Montgomery SA, Kasper S (2007) Severe depression and antidepressants: Focus on a pooled analysis of placebo-controlled studies on agomelatine. Int Clin Psychopharmacol 22:283–291

Mulsant BH, Sweet RA, Rosen J et al (2001) A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression in late life. J Clin Psychiatry 62:597–604

National Institute for Clinical Excellence (2004) Depression: Management of depression in primary and secondary care. http://www.Nice.Org.Uk/Pdf/CG023quickrefguide.Pdf Clinical Guideline 23

National Institute of Mental Health (1976) 028 CGI. Clinical Global Impressions. In: Guy W, Bonato RR (eds) Manual for the EDCEU Assessment Battery, 2. Rev. Chevy Chase, Maryland, pp 12-1–12-6

Novick JS, Stewart JW, Wisniewski SR et al (2005) Clinical and demographic features of atypical depression in outpatients with major depressive disorder: Preliminary findings from STAR*D. J Clin Psychiatry 66:1002–1011

Pandi-Perumal SR, Trakht I, Srinivasan V et al (2008) Physiological effects of melatonin: Role of melatonin receptors and signal transduction pathways. Prog Neurobiol

Parker G (2007) Defining melancholia: the primacy of psychomotor disturbance. Acta Psychiatr Scand 115:21–30

Patten SB (2006) Does almost everybody suffer from a bipolar disorder? Can J Psychiatry 51:6–8

Peet M (1994) Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. Br J Psychiatry 164:549–550

Pezawas L, Angst J, Kasper S (2005) Recurrent brief depression revisited. Int Rev Psychiatry 17:63–70

Pezawas L, Stamenkovic M, Kasper S (2001) Recurrent brief depressive episodes. Epidemiology, clinical aspects, diagnosis and therapy. Nervenarzt 72:169–180

Praschak-Rieder N, Neumeister A, Hesselmann B et al (1997) Suicidal tendencies as a complication of light therapy for seasonal affective disorder: A report of three cases. J Clin Psychiatry 58:389–392

Price LH, Conwell Y, Nelson JC (1983) Lithium augmentation of combined neuroleptic-tricyclic treatment in delusional depression. Am J Psychiatry 140:318–322

Riemann D, Voderholzer U, Cohrs S et al (2002) Trimipramine in primary insomnia: Results of a polysomnographic double-blind controlled study. Pharmacopsychiatry 35:165–174

Rocca P, Fonzo V, Ravizza L et al (2002) A comparison of paroxetine and amisulpride in the treatment of dysthymic disorder. J Affect Disord 70:313–317

Rohland BM, Carroll BT, Jacoby RG (1993) ECT in the treatment of the catatonic syndrome. J Affect Disord 29:255–261

Rosenthal NE, Sack DA, Carpenter CJ et al (1985) Antidepressant effects of light in seasonal affective disorder. Am J Psychiatry 142:163–170

Saarto T, Wiffen PJ (2005) Antidepressants for neuropathic pain. Cochrane Database Syst Rev CD005454

Sachs GS, Lafer B, Stoll AL et al (1994) A double-blind trial of bupropion versus desipramine for bipolar depression. J Clin Psychiatry 55:391–393

Sartorius N, Baghai TC, Baldwin DS et al (2007) Antidepressant medications and other treatments of depressive disorders: A CINP Task Force report based on a review of evidence. Int J Neuropsychopharmacol 10 [Suppl 1]:1–207

Schüle C, Baghai TC, Rupprecht R (2007) New insights into the pathogenesis and pathophysiology of depression. Nervenarzt 78 [Suppl 3]:531–547

Shelton RC, Andorn AC, Mallinckrodt CH et al (2007) Evidence for the efficacy of duloxetine in treating mild, moderate, and severe depression. Int Clin Psychopharmacol 22:348–355

Shorter E (2007) The doctrine of the two depressions in historical perspective. Acta Psychiatr Scand 115:5–13

Simon GE, VonKorff M, Piccinelli M et al (1999) An international study of the relation between somatic symptoms and depression. N Engl J Med 341:1329–1335

Sogaard J, Lane R, Latimer P et al (1999) A 12-week study comparing moclobemide and sertraline in the treatment of outpatients with atypical depression. J Psychopharmacol 13:406–414

Starkstein SE, Petracca G, Teson A et al (1996) Catatonia in depression: Prevalence, clinical correlates, and validation of a scale. J Neurol Neurosurg Psychiatry 60:326–332

Steinmeyer EM, Moller HJ (1992) Facet theoretic analysis of the Hamilton-D scale. J Affect Disord 25:53–61

Stewart JW, McGrath PJ, Quitkin FM, Klein DF (2007) Atypical depression: Current status and relevance to melancholia. Acta Psychiatr Scand 115:58–71

Taylor MA, Fink M (2003) Catatonia in psychiatric classification: A home of its own. Am J Psychiatry 160:1233–1241

Thase ME (1999) Antidepressant treatment of the depressed patient with insomnia. J Clin Psychiatry 60 [Suppl 17]:28–31

Tran PV, Bymaster FP, McNamara RK, Potter WZ (2003) Dual monoamine modulation for improved treatment of major depressive disorder. J Clin Psychopharmacol 23:78–86

Uebelhack R, Gruenwald J, Graubaum HJ, Busch R (2004) Efficacy and tolerability of Hypericum extract STW 3-VI in patients with moderate depression: A double-blind, randomized, placebo-controlled clinical trial. Adv Ther 21:265–275

Volz HP, Laux P (2000) Potential treatment for subthreshold and mild depression: a comparison of St. John’s wort extracts and fluoxetine. Compr Psychiatry 41:133–137

World Health Organization (1992) The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva, Switzerland

World Health Organization (2005) Depression. WHO Report on Mental Health http://www.who.int/mental_health/management/depression/definition/en/

Yatham LN (2005) Atypical antipsychotics for bipolar disorder. Psychiatr Clin North Am 28:325–347

Zanardi R, Franchini L, Gasperini M et al (1996) Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression. Am J Psychiatry 153:1631–1633

Zanardi R, Franchini L, Gasperini M et al (1997) Long-term treatment of psychotic (delusional) depression with fluvoxamine: An open pilot study. Int Clin Psychopharmacol 12:195–197

Zanardi R, Smeraldi E (2005) A double-blind, randomised, controlled clinical trial of acetyl-l-carnitine vs. amisulpride in the treatment of dysthymia. Eur Neuropsychopharmacol